GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAssets Inc (NAS:MDAS) » Definitions » Earnings Power Value (EPV)

MedAssets (MedAssets) Earnings Power Value (EPV) : $-5.31 (As of Sep15)


View and export this data going back to . Start your Free Trial

What is MedAssets Earnings Power Value (EPV)?

As of Sep15, MedAssets's earnings power value is $-5.31. *

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

Margin of Safety is N/A.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.


MedAssets Earnings Power Value (EPV) Historical Data

The historical data trend for MedAssets's Earnings Power Value (EPV) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAssets Earnings Power Value (EPV) Chart

MedAssets Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Earnings Power Value (EPV)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.81 -10.56 -8.12 -5.23 -7.10

MedAssets Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Earnings Power Value (EPV) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.42 -7.10 -6.40 -5.47 -5.31

Competitive Comparison of MedAssets's Earnings Power Value (EPV)

For the Health Information Services subindustry, MedAssets's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAssets's Earnings Power Value (EPV) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAssets's Earnings Power Value (EPV) distribution charts can be found below:

* The bar in red indicates where MedAssets's Earnings Power Value (EPV) falls into.



MedAssets Earnings Power Value (EPV) Calculation

Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.

MedAssets's "Earning Power" Calculation:

Average of Last 20 Quarters Last Quarter
Revenue 658.4
DDA 106.6
Operating Margin % 6.66
SGA * 25% 71.5
Tax Rate % 32.72
Maintenance Capex 51.6
Cash and Cash Equivalents 0.0
Short-Term Debt 26.8
Long-Term Debt 770.9
Shares Outstanding (Diluted) 59.4

1. Start with "Earnings" not including accounting adjustments (one-time charges not excluded unless policy has changed). "Earnings" are "Operating Income.

2. Look at average margins over a business/Industry cycle: Average Operating Margin = 6.66%

To normalize margins and eliminate the effects on profitability of valuing the firm at different points in the business cycle, it is usually best to take a long-term average of operating margins. Ideally this would be as long as 10 years and include at least one economic downturn. However, since most of companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year margin.

3. Multiply average margins by sustainable revenues and then adjust for maintenance SGA. This yields "normalized" EBIT:

To be conservative, GuruFocus uses an average of the 5 year revenues as the sustainable revenue.
EPV analysis recognises that part of SG&A expenditure is made to maintain and replace the existing assets, while part is made to grow sales. Since EPV is only interested in what it costs a going concern to maintain its existing asset base, it adds back a percentage of SG&A (between 15% and 50% - this is a matter of judgment and industry knowledge) to make up for the fact that some of this expenditure went to fund growth and shouldn't be accounted for. To start off, we assume 25% for the sake of prudence.
Sustainable Revenue = $658.4 Mil, Average Operating Margin = 6.66%, Average Adjusted SGA = 71.5,
therefore "Normalized" EBIT = Sustainable Revenue * Average Operating Margin + Average Adjusted SGA = 658.4 * 6.66% +71.5 = $115.35366724 Mil.

4. Multiply by one minus Average Tax Rate (NOPAT):

Same as average operating margin calculation, GuruFocus takes an average of the 5 years tax rates.
Average Tax Rate = 32.72%, and "Normalized" EBIT = $115.35366724 Mil,
therefore After-tax "Normalized" EBIT = "Normalized" EBIT * ( 1 - Average Tax Rate ) = 115.35366724 * ( 1 - 32.72% ) = $77.609370550736 Mil.

5. Add back Excess Depreciation (after tax at 1/2 average tax rate). This yields "normalized" Earnings:

Excess Depreciation = Average DDA * % of Excess Depreciation (after tax at 1/2 average tax rate) = 106.6 * 0.5 * 32.72% = $17.4365254065 Mil.
"Normalized" Earnings = After-tax "Normalized" EBIT + Excess Depreciation = 77.609370550736 + 17.4365254065 = $95.045895957236 Mil.

6. Adjusted for Maintenance Capital Expenditure:

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Third, calculate Capital Expenditure (positive) - percentage of Net PPE as of corresponding Revenue * revenue increase.
If [Capital Expenditure (positive) - percentage of Net PPE as of corresponding Revenue * revenue increase] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - percentage of Net PPE as of corresponding Revenue * revenue increase] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - percentage of Net PPE as of corresponding Revenue * revenue increase.
Fourth, GuruFocus uses an average of the 5 year maintenance capital expenditures as maintenance CAPEX.
MedAssets's Average Maintenance CAPEX = $51.6 Mil *.
* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

7. Investors require a return of "WACC" for the risk they are taking: WACC = 9%

8. MedAssets's current cash and cash equivalent = $0.0 Mil.
MedAssets's current interest bearing debt = Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation = 770.9 + 26.8 = $797.656 Mil.
MedAssets's current Shares Outstanding (Diluted Average) = 59.4 Mil.

MedAssets's Earnings Power Value (EPV) for Sep15 is calculated as:

EPV = ( ( Norm. Earnings-Maint. CAPEX *) / WACC + CashandEquiv - Int. Bearing Debt ) / Shares Outstanding (Diluted Average)
= ( ( 95.045895957236 - 51.6)/ 9%+0.0-797.656 )/59.4
=-5.31

Margin of Safety (EPV)=( Earnings Power Value (EPV)-Current Price )/Earnings Power Value (EPV)
=( -5.3061119883732-31.35 )/-5.3061119883732
= N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.


MedAssets  (NAS:MDAS) Earnings Power Value (EPV) Explanation

Assumption: Current profitability is sustainable.

Earnings power value (EPV) uses a very basic equation which assumes no growth, although it does rely on an assumption about the cost of capital as well as the fact that current earnings are sustainable. It also involves several adjustments to clean up the underlying Earnings figures.


Be Aware

Though using today's earnings in calculating Earnings Power Value, GuruFocus is normalizing these earnings to the business cycle. This eliminates the effects on profitability of valuing the firm at different points in the business cycle. This means that we are considering the average earnings over 5 years.


MedAssets Earnings Power Value (EPV) Related Terms

Thank you for viewing the detailed overview of MedAssets's Earnings Power Value (EPV) provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAssets (MedAssets) Business Description

Traded in Other Exchanges
N/A
Address
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
Executives
Anthony Jr Colaluca officer: Chief Financial Officer MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
Bharat Sundaram officer: President, SCM Segment 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
C A Piccolo director 199 BENSON RD, MIDDLEBURY CT 06749
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Kevin M Twomey director 1650 PRUDENTIAL DR, STE 400, JACKSONVILLE FL 32207
Bruce F Wesson director 1827 PACIFIC ST BROOKLYN NY 11233
R Halsey Wise director, officer: Chairman and CEO 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Samuel K Skinner director 233 NORTH MICHIGAN AVENUE, 22ND FLOOR, CHICAGO IL 60601
Loucks Vernon R Jr director 1101 SKOKIE BLVD., SUITE 240, NORTHBROOK IL 60062
Laurence Neil Hunn officer: President, Revenue Cycle Tech 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Patrick T Ryan director, officer: President, SCM Segment 401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880
Claudius Llc 10 percent owner C/O GALEN ASSOCIATES 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Partners Iii L P 10 percent owner 610 FIFTH AVE 5TH FL NEW YORK NY 10020
Galen Partners International Iii L P 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Employee Fund Iii Lp 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020

MedAssets (MedAssets) Headlines

From GuruFocus

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 02-09-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 6,000 Shares

By GuruFocus Research GuruFocus Editor 05-07-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 4,300 Shares

By GuruFocus Research GuruFocus Editor 07-08-2010

MEDASSETS, INC. (MDAS) CFO Laurence Neil Hunn sells 3,100 Shares

By GuruFocus Research GuruFocus Editor 07-08-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 54,000 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 01-05-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 6,000 Shares

By GuruFocus Research GuruFocus Editor 06-09-2010

MEDASSETS, INC. (MDAS) CFO Laurence Neil Hunn sells 3,100 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 2,800 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) CFO Laurence Neil Hunn sells 3,100 Shares

By GuruFocus Research GuruFocus Editor 04-16-2010